Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(17%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(3)
Other(2)

Detailed Status

Completed3
unknown2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed350%
unknown233%
active_not_recruiting117%

Recent Activity

1 active trials
Showing 5 of 6
active_not_recruiting

Non-contrast DWI for Supplemental Screening

NCT03607552
completednot_applicable

Pain in Fibrous Dysplasia

NCT04125862
completed

Lymphatic Morphology of Fontan Patients

NCT04163653
completed

Non-invasive Quantification of Liver Iron With MRI

NCT01516853
unknownnot_applicable

Usefulness of Non-contrast MagnetIc Resonance imAging Versus Non-Contrast Ultrasonography for surveiLlancE of HepatoCellular Carcinoma [MIRACLE-HCC]

NCT02514434
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT03607552

Non-contrast DWI for Supplemental Screening

Active Not Recruiting
NCT04125862Not Applicable

Pain in Fibrous Dysplasia

Completed
NCT04163653

Lymphatic Morphology of Fontan Patients

Completed
NCT01516853

Non-invasive Quantification of Liver Iron With MRI

Completed
NCT02514434Not Applicable

Usefulness of Non-contrast MagnetIc Resonance imAging Versus Non-Contrast Ultrasonography for surveiLlancE of HepatoCellular Carcinoma [MIRACLE-HCC]

Unknown
NCT03379805

Lymphatic Function in Patients With a Fontan-Kreutzer Circulation

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
6